Biolife Solutions Inc (BLFS): Operating Cash Flow
$20.11M
Year ended 2025-12-31
$16.88M
Trailing 12 months to 2026-06-30
+24.8%
5-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $20.11M | +138.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $8.43M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$12.50M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$8.49M | n/m | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | -$4.59M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $6.64M | +447.8% | 2023-03-31, From 2020-01-01 |
| 2019-12-31 | $1.21M | -48.3% | 2022-03-31, From 2019-01-01 |
| 2018-12-31 | $2.35M | +288.1% | 2020-05-15, From 2018-01-01 |
| 2017-12-31 | $605.0K | n/m | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | -$4.33M | n/m | 2018-03-09, From 2016-01-01 |
| 2015-12-31 | -$4.97M | n/m | 2016-02-25, From 2015-01-01 |
| 2014-12-31 | -$3.16M | n/m | 2016-02-25, From 2014-01-01 |
| 2013-12-31 | $146.0K | -82.9% | 2015-03-12, From 2013-01-01 |
| 2012-12-31 | $854.9K | n/m | 2014-02-12, From 2012-01-01 |
| 2011-12-31 | -$989.9K | n/m | 2013-03-29, From 2011-01-01 |
| 2010-12-31 | -$1.25M | n/a | 2012-03-29, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $20.11M | +138.6% |
| Vaso Corp (VASO) | 2025-12-31 | $9.27M | +182.6% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | -$40.81M | n/m |
| Outset Medical, Inc. (OM) | 2025-12-31 | -$46.33M | n/m |
| Electromed, Inc. (ELMD) | 2026-06-30 | $9.66M | -15.2% |
| Iridex Corp (IRIX) | 2026-01-03 | -$2.12M | n/m |
| Axogen, Inc. (AXGN) | 2025-12-31 | $812.0K | -82.1% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | -$13.69M | n/m |
| electroCore, Inc. (ECOR) | 2025-12-31 | -$8.19M | n/m |
Compare BLFS, VASO, CBLL, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗